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Aortic dissection is a life-threatening condition
characterised by high early mortality. While general
consensus exists regarding the need of immediate
surgical repair for patients with acute ascending aortic
dissection, the optimal treatment strategy for type B
aortic dissection continues to be a matter of debate. It
has been generally advocated that patients who have
type B aortic dissection without complications should
be treated with medical therapy, historically based on
the Wheat’s concept of antiimpulse therapy,1 decreas-
ing the force of cardiac contraction and systolic blood
pressure acting upon the weaker aortic wall. With
aggressive antihypertensive therapy up to 85% of
patients may survive their initial hospital stay.
However, about 30% of acute type B dissections at
clinical presentation are complicated by peripheral
vascular ischemia or hemodynamic instability, which
results in high risk of spontaneous death.
The perception that prognosis of type B dissection is
better with medical management mostly derives from
the negative results for descending aorta surgery.2–14
Direct aortic replacement for acute aortic dissection
showed significant mortality and paraplegia rate, even
in the outstanding Crawford–Svennson data,5,6 report-
ing 30–36% of paraplegia for extensive aortic replace-
ment for dissection. Long-term follow-up of patients
with type B dissection showed unsatisfactory outcome
even after successful initial stabilization and optimal
medical therapy. Mortality is related either to retro-
grade progression of dissection with involvement ofing author. Rossella Fattori, Istituto di Cardiologia
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and formation of a thoracic aneurysm. Several reports
in the literature analysed long-term outcome in
patients with type B dissection, comparing medical
with surgical therapy without evidence of a significant
difference between the two groups.1–14 A large retro-
spective analysis of Umana and colleagues4 has
recently focused on long-term outcome comparison
(36 years) between medical and surgical therapy in 189
patients after acute type B dissection. The actuarial
survival estimates for all patients were 71, 60, 35, and
17% at 1, 5, 10, and 15 years, respectively, and were
similar for the medical and surgical patients, indicat-
ing that medical therapy appears to confer some
survival advantage only in the short term but fails to
demonstrate any significant advantage in the long
term.
These suboptimal results have prompted the need
of investigation for alternative procedures, which
could combine low invasiveness and durable results.Rationale and Early Results of Endovascular
Treatment of Aortic Dissection
The rationale of endovascular treatment of aortic
dissection was originally based on evidence in the
literature15,16 of protective effect of false lumen
thrombosis against false lumen (FL) expansion and
on the clinical observation that patients in the rare
instance of spontaneous thrombosis of the FL have a
better long-term prognosis than without it. Conver-
sely, persistent perfusion of the FL has been identified
as an independent predictor of progressive aortic
enlargement and adverse long-term outcome.17Eur J Vasc Endovasc Surg 31, 115–122 (2006)
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promote both depressurisation and shrinkage of the
false lumen, with subsequent thrombosis, fibrous
transformation, remodelling and stabilization of the
aorta (Fig. 1).
Using the terms aorta, type B dissection, and stent-
graft, a comprehensive search of the English-language
literature from January 1999 to July 2005 was
performed, using the Medline database. All studiesFig. 1. (A) and (B) MDCT images of type B aortic dissection.
The entry site is visible in the volume rendering reformation
(B) 2 cm below the left subclavian artery.
Eur J Vasc Endovasc Surg Vol 31, 2 2006focused on endovascular stent-graft treatment of aortic
dissection were considered in order evaluate current
results with respect to complications and outcome
(Table 1). The first report on stent-graft treatment in
type B aortic dissection appeared in 1999, in two dif-
ferent series of acute and chronic patients. Dake et al.18
reported a series of 19 patients with acute dissections
treated with homemade devices. Technical success
was achieved in all cases. The 30-day mortality rate
was 13%. Serious morbidity occurred in three (20%) of
these 15 patients. Three patients had persistent flow in
the false lumen that had resolved at the 1-month CT
scan. All dynamic branch vessel occlusions were
corrected by endograft coverage of the proximal
entry tear. No subsequent deaths or aneurysm
ruptures occurred in a follow-up of 13 months.
Nienaber et al.19 compared 12 patients with chronic
type B dissection and aneurismal degeneration (O
5.5 cm) treated with commercial available stent-graft
device to 12 concurrent patients treated with conven-
tional open surgical repair. Technical success was
100% in the endovascular group, with 10 of 12 patients
having immediate thrombosis of the false lumen on
intraoperative transesophageal echocardiography
(TEE). No patient in the endovascular group died
during the 12-month study there was not a single
instance of spinal cord ischemia, whereas 33% of the
surgical patients died. After this initial experience,
several single-center reports have shown technical
feasibility and clinical safety of endovascular tech-
niques in type B dissection.20–41
The widest published series is the combined
experience of EUROSTAR registry (European Collab-
orators on Stent Graft Techniques for Thoracic Aortic
Aneurysm and Dissection Repair) and the United
Kingdom Thoracic Endograft registry.40 The initial and
1-year outcome of endovascular treatment of 443
patients is reported and among them, 131 had aortic
dissection. Sixty-two of them were treated under
emergency conditions and 42% were at high risk for
conventional open surgery. Primary technical success
was achieved in 89% of patients; the remaining 11%
had either incomplete covering of the entry tear,
persistent flow without thrombosis of the largest
portion of the false lumen, no expansion of the true
lumen, or endoleak. Neurological complications con-
sisted of paraplegia in one patient who underwent
emergency repair, and stroke in two patients who
underwent elective procedures. The overall 30-day
mortality rate was 8.4%. One year after treatment 94%
of patients followed up during this interval (67
patients) had satisfactory findings at CT examination.
New endoleaks were observed in 2.8% of patients.
Table 1. Endovascular treatment of Type B aortic dissection: results in the literature
Author Year Pts Technical
success
Emergency
conversion
Complications:
overall
Complications:
stroke
Complications:
paraplegia
30-day
mortality
Late surgical
conversion
Late aortic
rupture
Dake18 1999 19 19 0 4 0 0 3 0 0
Nienaber19 1999 12 12 0 0 0 0 0 0 0
Czermak20 2000 7 6 0 2 0 0 0 1 0
Hausegger21 2001 5 5 0 1 0 0 0 0 0
Kang22 2001 6 6 0 0 0 0 0 0 0
Sailer23 2001 7 7 0 n.a. 0 0 0 0 0
Tiesenhausen24 2001 4 4 0 0 0 0 0 0 0
Bortone25 2002 12 12 0 1 0 0 1 0 0
Herold28 2002 18 18 0 3 0 0 1 0 2
Hutschala27 2002 9 9 0 1 1 1 0 0 0
Kato26 2002 38 38 0 9 1 0 2 2 1
Nienaber29 2002 127 127 0 4 2 1 2 n.a. 3
Palma30 2002 58 65 2 n.a. 2 0 4 3 2
Pamler31 2002 14 14 2 4 1 1 0 0 0
Quinn32 2002 15 15 0 3 0 0 4 0 0
Rousseau33 2002 20 20 1 2 1 0 2 1 1
Shim34 2002 15 14 0 0 0 0 1 2 0
Beregi35 2003 12 11 0 4 1 0 2 0 1
Lonn36 2003 20 20 0 10 5 1 3 0 0
Lopera37 2003 10 9 0 2 1 0 0 0 2
Dialetto38 2004 28 28 0 1 0 0 3 0 0
EUROSTAR/UKTE
registries40
2004 131 117 0 n.a. 2 1 1 1 0
Nathanson41 2005 40 38 0 15 1 1 1 0 0
Eggebrecht39 2005 38 38 0 4 0 0 4 1 3
Total 665 652 5 70 18 6 34 9 12
% 98 0.7 18.9 2.7 0.9 5.1 1.3 1.8
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Table 2. Anatomic details of aortic dissection with the different imaging modalities
Non-invasive-
ness
Measurements Entry site Arch anatomy TL/VL, visceral
vessels
Iliac access
CT (standard) CCKK CCKK CKKK CKKK CCKK CCCK
MDCT KCCC CCCC CCCC CCCC CCCC CCCC
MRI CCCC CCCC CCCK CCCC CCCC CCCK
ANGIO KKKK CKKK CCCK CCCC CCCC CCCC
TEE CCKK CCKK CCCC CCKK KKKK KKKK
R. Fattori et al.118Late death occurred in 1.5% of patients, and the
cumulative survival rate after 1 year was 90%.
The talent thoracic retrospective registry (TTR)
analysed data on patients who underwent endovas-
cular treatment of the thoracic aorta in seven European
referral centers with the Talent device (unpublished
data). Four hundred and fifty seven patients have been
enrolled and among them 180 had type B dissection.
The in-hospital mortality did not differ between
patients with dissection as compared to other aortic
diseases: there was 5% of mortality for the whole
group and 4.5% in-hospital mortality for patients with
type B dissection. Of note, the only two patients of the
entire series who died during the interventional
procedure were type B dissection patients treated
under emergency conditions. During the follow-up,
which has been complete in 422 patients (mean 24
months ranging from 1 to 85 months), no statistical
difference was observed in long term mortality and
outcome between patients treated with endovascular
stent-graft for aortic dissection or for other thoracic
aortic diseases.
The INSTEAD trial was designed as a multicenter,
randomized trial that is ongoing in Europe.42 The
purpose of the study is to compare the outcomes of
type B aortic dissection subjected to interventional
thoracic stent grafting combined as an adjunct with
tailored antihypertensive treatment (stent-graft group)
to those of tailored antihypertensive treatment alone
(medical treatment group). Acute cases are excluded
as well as chronic long-standing aortic dissection (O24
months from initial clinical presentation). Results from
INSTEAD trial are expected in 2006.
Published data confirm the technical feasibility and
a relative low rate of complications with respect to
surgical repair (Table 1). However, long-term follow-
up and outcome information, in order to document the
sustained benefit of endovascular repair, are still
limited. With growing experience in endovascular
stent-graft treatment the spectrum of acute and
midterm complications has broadened to include
potentially disastrous events. Late aneurismal
degeneration of the thrombosed false lumen has
been reported by Kato et al.,43 and also several case
reports have highlighted the risk of retrogradeEur J Vasc Endovasc Surg Vol 31, 2 2006extension of the dissection into the ascending aorta,
potentially caused by stent-graft induced intimal
injury.44 Even though extension of dissection is
known event in the course of type B dissection disease,
wire or sheath manipulation during the endovascular
procedure could increase the risk of this dreadful
complication. Continuous progress in stent-graft
technology, improving morphology and flexibility,
may lead to more suitable stent-graft configuration
for aortic dissection. However, these unexpected
complications underline the particular fragility of the
aortic wall and the need of careful selection criteria
and rigorous follow-up.Imaging Evaluation Before Endovascular
Treatment
Knowledge regarding the extent and specific patho-
physiology and anatomy of each dissection is critical
prior to intervention. In the diagnostic work up of
patients candidate to endovascular treatment of type B
dissection, high resolution imaging modalities such as
MRI and MDCT, are fundamental in order to define
the essential anatomic characteristics and are on the
basis of procedural success.45–47 The identification of
the entry and re-entry tears, the relationship between
true and false lumen and visceral vessels, the iliac
arteries involvement, are all crucial information for
patient selection and stent-graft design, which can be
assessed non-invasively. Therefore, catheter angiogra-
phy should be reserved only in patients in whom the
other modalities have been unable to identify the
necessary anatomic details (Table 2).The Role of Transesophageal Echocardiography
(TEE)
TEE can be highly useful in the operating room to
guide a correct stent positioning in type B aortic
dissection, visualizing a safe advancement of stent-
graft device in the true lumen and its position in front
of the entry site. The support of color-Doppler,
differentiating true lumen from false lumen, as well
Endovascular Treatment of Dissection 119as the entry sites, can accurately display flow
dynamics. Stent deployment can be monitored by
fluoroscopy using the TEE probe as a marker facing
the selected area, avoiding the need of repeated
contrast medium injections. Because TEE offers
multiple angulations images, accurate measurements
can be assessed in order to select the optimal size of the
stent-graft. This attribute is particularly useful in
emergency procedures, in which the risk of rupture
may not allow to perform CT or MRI evaluation before
the procedure. After stent deployment, TEE with
color-Doppler is more sensitive than angiography in
identifying endoleak (usually velocity R100 cm/s).
Endoleak due to incomplete stent-graft apposition to
the aortic neck or at segment junction can be resolved
by balloon inflation. Again TEE guidance of balloon
inflation can detect complete balloon expansion,
avoiding overstretching and potential damage of the
aortic wall.48 It is also important to recognize thoracic
re-entries, detectable only after stent implantation
after the closure of the main entry site, in order to
avoid false lumen reperfusion by retrograde flow.
Monitoring of thrombus formation with successful
sealing of entries is due to the sensitivity of TEE for
slow flow as an early sign of clot formation in the false
lumen after aortic stent-graft placement and direct
sign of the success of the procedure.Imaging Follow-up After Stent-graft Placement
The goal of endovascular treatment in type B
dissection is to provide false lumen thrombosis and
aortic remodelling with false lumen expansion.
Thrombosis of the false lumen in the thoracic aorta
should be rather immediate after stent-graft closure of
the thoracic entry and re-entry sites, while aortic
remodelling is a slow process, which typically needs
several days or months. After treatment, a strict
imaging follow-up is mandatory, because endoleak
may cause false lumen expansion and increase the risk
of aortic rupture.49 Both MRI and CT are reliable
techniques, even if CT scan has the advantage of being
able to depict the stent-graft material with high
accuracy, while on MRI the metallic component of
the stent-graft provides artefacts, thus limiting the
evaluation of aortic wall conditions and peri-graft
zone. It is important to remind that slow flow endoleak
can be missed by the short acquisition time of both CT
and MR angiography. Therefore, a second delayed
acquisition (30–60 s) after the arterial phase should be
performed, in order to exclude any residual flow in the
false lumen.50 Accurate measurement of true and false
lumen dimension are also important for indirectassessment of procedural success, because aortic
remodelling with false lumen shrinkage and true
lumen expansion is frequent in the absence of
endoleak.Percutaneous Management of Malperfusion
Aortic branch-vessel obstruction is one of the most
important causes of morbidity and mortality in type B
dissection and constitutes a challenge for medical and
surgical treatment of the disease. The incidence of
aortic branch vessels compromise in association with
aortic dissection ranges from 25 to 50%.51 Ischemic
complications can arise when the dissection compro-
mises blood flow, by either extrinsic compression of
the true lumen by the false channel or an intimal flap
occluding the orifice of a branch artery. Immediate
correction of these abnormalities is necessary to
preserve end-organ function. Surgical fenestration,
first successfully performed by DeBakey in 1955, has
spread out in the 90s with large series reported by
Elefteriades et al. and Cambria et al.52–55 To this day,
aortic fenestration is still a rarely performed pro-
cedure, and surgical series have remained limited. The
advantage of surgical fenestration is to be a durable
procedure with no late recurrence of malperfusion.
However, despite a wide array of operative strategies,
the operative mortality rate for patients with acute
aortic dissection complicated by renal ischemia has
been upwards of 50% and as high as 88% when
mesenteric perfusion is impaired.
Williams et al. first described percutaneous tech-
nique of aortic fenestration in 199056 reporting
successful resolution of mesenteric ischemia from
subacute aortic dissection by percutaneous balloon
fenestration. However, despite the reperfusion suc-
cess, the dissected aorta showed progressive enlarge-
ment, necessitating thoracoabdominal aortic
replacement 6 weeks later. Since then, several small
series has been reported using a variety of techniques
in different indications.57–61 Slonim et al.57 reported
results of 6 years experience of percutaneous fenestra-
tion on 40 patients. Successful revascularization was
achieved in 93%. However, 30-day mortality was 25%
due to multiorgan failure or aortic rupture. Williams
et al.59 recently reported their endovascular experience
with 24 patients with peripheral vascular compli-
cations from aortic dissection. They reported a 92%
success rate at restoring flow into compromised
branch vessels. However, they had a 25% 30-day
mortality rate and had an immediate ischemic
recurrence rate of 8% (2/24). After aortic balloon
fenestration, four patients had significantEur J Vasc Endovasc Surg Vol 31, 2 2006
R. Fattori et al.120complications from the false lumen such as rupture,
false lumen expansion and paraplegia from retrograde
thrombosis.
The purpose of percutaneous balloon fenestration is
to create a communication between the two aortic
lumens homogenizing the pressure and the flow in
both the lumens and in branch vessels. A curved,
hollow metal needle is employed, introduced into the
sheath over a stiff guide wire and advanced above the
level to be punctured, under intravascular ultrasound
(US) guidance, usually in the infrarenal aorta or the
iliac bifurcation. The metal stylet, with a coaxially
mounted 5-F catheter, is inserted to just inside the
needle tip. After the puncture the stylet is removed
and the 5-F catheter left in position across the flap.
With an over-the wire exchange technique, an
appropriate-sized (15–25-mm), low profile balloon is
inserted through the sheath and positioned across the
flap and inflated. Pressure measurement attesting noFig. 2. (A) and (B) MDCT images after stent-graft treatment:
complete thrombosis of the false lumen and aortic remodel-
ling with true lumen expansion and FL shrinkage. (A)
Transesophageal echocardiography image of a patient with
acute type B dissection and malperfusion syndrome. The
false lumen is enlarged and compresses the true lumen.
There is a slow flow in both true lumen and false lumen
(smoking effect). (B) After stent deployment: immediate
normalization of flow with true lumen expansion.
Eur J Vasc Endovasc Surg Vol 31, 2 2006gradient between the two lumens assesses the efficacy
of fenestration. On the basis of successful aortic
fenestration is an accurate imaging evaluation before
the procedure. Identification of the dissection anatomy
and extension, position and size of lumens, assessment
of branch vessel perfusion from true and false lumen,
the cause and degree of obstruction of the involved
branch vessels such as flap prolapse into the vessel, are
essential information.
Overall technical success in revascularization
exceeds 90%. Rupture of the dissected aorta, although
a real risk, seems to be an uncommon procedural
complication, but there is still potential for extension
of the dissection in spite of fenestration. Percutaneous
transluminal balloon angioplasty with intravascular
stent may be sometimes necessary in cases of localized
fibrous stenosis in major aortic tributaries or prolapse
mechanism of the intimal flap. The role of fenestration
the era of stent-graft placement is also unclear. Usually,
the stent-graft occlusion of the entry site results in
thrombosis of the false channel and flow increase in
the true lumen, therefore, normalizing the vessel
perfusion and restoring branch vessels patency
(Fig. 2). Therefore, immediate relief of malperfusion
syndrome may be the first results of endovascular
stent-graft treatment of aortic dissection.Conclusion
In the difficult management of descending aortic
dissection endovascular treatment represents a prom-
ising alternative to medical therapy and surgical
repair, with the prospective of better long-term
survival. Understanding of the pathologic condition,
careful attention to the dissection anatomy and
progress in stent-graft technology, will be essential in
improving technical skill and procedural results. Until
the results of randomized comparative trial of medical
versus endovascular therapy will be available, indi-
cation to endovascular repair of type B dissection
should be considered the same applied to surgical
repair, namely acute unstable cases or chronic
aneurysmal expansion (usually O5.5 cm). At present
long term follow-up data are scarsely reported. As yet,
no literature data support the expansion of stent-graft
treatment in asymptomatic, stable patients with type B
dissection, until a clear survival benefit will be proved.
The risk of unexpected complications and the potential
need for reinterventions underline the importance of
rigorous selection criteria and strict lifelong
surveillance.
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